Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Jun 11  •  04:00PM ET
0.1812
Dollar change
-0.0295
Percentage change
-14.00
%
Jun 10, 4:05 AMKuehn Law shareholder investigation triggers 20% PMI premarket drop
Index
RUT
P/E
-
EPS (ttm)
-0.45
Insider Own
79.48%
Shs Outstand
75.26M
Perf Week
-43.29%
Market Cap
16.74M
Forward P/E
-
EPS next Y
-0.09
Insider Trans
0.00%
Shs Float
18.95M
Perf Month
1.80%
Enterprise Value
19.89M
PEG
-
EPS next Q
-0.03
Inst Own
0.43%
Perf Quarter
-85.95%
Income
-29.85M
P/S
3.05
EPS this Y
77.33%
Inst Trans
-0.08%
Perf Half Y
-93.08%
Sales
5.48M
P/B
-
EPS next Y
47.06%
ROA
-250.68%
Perf YTD
-89.65%
Book/sh
-0.02
P/C
139.46
EPS next 5Y
-
ROE
-
52W High
13.68 -98.68%
Perf Year
-
Cash/sh
0.00
P/FCF
-
EPS past 3/5Y
-27.88% -
ROIC
-
52W Low
0.11 64.73%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
6.30% -
Gross Margin
7.14%
Volatility
34.03% 27.90%
Perf 5Y
-
Dividend TTM
-
EV/Sales
3.63
EPS Y/Y TTM
-19.57%
Oper. Margin
-265.15%
ATR (14)
0.08
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.16
Sales Y/Y TTM
80.70%
Profit Margin
-545.06%
RSI (14)
38.24
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.75
EPS Q/Q
-16.65%
SMA20
-8.98%
Beta
-
Target Price
-
Payout
-
Debt/Eq
-
Sales Q/Q
85.48%
SMA50
-62.71%
Rel Volume
0.26
Prev Close
0.21
Employees
75
LT Debt/Eq
-
SMA200
-93.73%
Avg Volume
27.00M
Price
0.18
IPO
Aug 29, 2025
Option/Short
No / Yes
Trades
Volume
6,925,847
Change
-14.00%
Date Action Analyst Rating Change Price Target Change
May-18-26Initiated H.C. Wainwright Neutral
Jun-02-26 07:00AM
May-29-26 07:00AM
May-21-26 07:00AM
May-05-26 08:00AM
Apr-30-26 08:00AM
08:00AM Loading…
Apr-29-26 08:00AM
Apr-22-26 07:00AM
Apr-16-26 06:56PM
Apr-15-26 08:00AM
Apr-12-26 11:59PM
Apr-02-26 08:00AM
Apr-01-26 08:00AM
Mar-25-26 07:00AM
Mar-24-26 03:43PM
Mar-23-26 02:56PM
09:00AM Loading…
Mar-20-26 09:00AM
08:00AM
Mar-19-26 08:00AM
Mar-17-26 07:00AM
Mar-13-26 06:00AM
Mar-12-26 04:05PM
Mar-02-26 08:00AM
Feb-26-26 08:00AM
Feb-23-26 08:00AM
Feb-14-26 11:26AM
Feb-12-26 08:30AM
Feb-10-26 04:05PM
Feb-05-26 04:05AM
Jan-29-26 04:05PM
Jan-13-26 09:00AM
08:30AM Loading…
Jan-12-26 08:30AM
Jan-07-26 08:00AM
Jan-06-26 08:00AM
Dec-30-25 08:00AM
Dec-26-25 06:25AM
Dec-24-25 09:36AM
Dec-18-25 08:55AM
08:30AM
Dec-09-25 04:05PM
Dec-03-25 04:05PM
Nov-26-25 07:00AM
Nov-19-25 04:05PM
Nov-14-25 07:00AM
Nov-12-25 08:00AM
Nov-03-25 08:00AM
Oct-24-25 03:07PM
Oct-08-25 10:51AM
Sep-22-25 08:00AM
Sep-15-25 08:00AM
Sep-10-25 08:00AM
Sep-09-25 04:05PM
Sep-08-25 07:00AM
Sep-02-25 04:05PM
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.
CEO & DirectorMr. Patrick N. J. Schnegelsberg
Chief Technology Officer of SynCardia SystemsDr. Frank Tinker Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sindex SSI Lending, LLC10% OwnerJun 03 '26Proposed Sale0.323,971,7931,259,853Jun 03 04:03 PM
Sindex SSI Lending, LLC10% OwnerJun 01 '26Proposed Sale0.183,971,793695,064Jun 01 05:36 PM